LAUREN FRANZA: Open Payments
NPI 1467179028 · GLASTONBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 24 payments from 5 companies in 2025. Trend: 2023 $110 · 2024 $921 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $200 |
| Janssen Pharmaceuticals, Inc | 4 | $195 |
| ABBVIE INC. | 11 | $181 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| Alkermes, Inc. | 1 | $25 |
Products named: CAPLYTA, SPRAVATO, VRAYLAR, FANAPT, QULIPTA, ARISTADA.
Industry payments across CT — which companies pay providers there.
